Assessment of depression symptoms in female cancer patients: focus on concurrent validity : Depression in female cancer

Alessandra Miraglia Raineri; Rosapia Lauro Grotto

doi:10.23750/abm.v91i2-S.9285

Assessment of depression symptoms in female cancer patients: focus on concurrent validity

Depression in female cancer

Authors

Alessandra Miraglia Raineri 1Department of Health Sciences, Psychology and Psychiatry Unit, University of Florence, Florence, Italy
Rosapia Lauro Grotto Department of Health Sciences, Psychology and Psychiatry Unit, University of Florence, Florence, Italy

DOI: https://doi.org/10.23750/abm.v91i2-S.9285

Keywords:

Depression;, Concurrent Validity;, Female Cancer, Hospital Anxiety Depression Scale, Beck Depression Inventory

Abstract

Background and aim of the work: The present research explores Concurrent Validity of two depression measures the Beck Depression Inventory (BDI) and the Depression Subscale of the Hospital Anxiety and Depression Scale (HADS- Depression subscale) in specific oncological groups (female cancer and onco-hematological patients). Method: A correlational study was designed and took place at Careggi Universitary Hospital in Florence, including 339 oncological patients, in particular 103 (59 Women and 44 men) patients suffering from lymphoma, and 236 patients suffering from female cancer. We estimated, by Pearson’s r, Concurrent Validity between BDI and HADS depression’s subscale. Results: Correlations failed to reach the 0.55 cut-off in the female cancer group (r=.34, p<.001) but not in the onco-hematological patients (r= 0.56, p<.001). Conclusion: The results stressing the need to develop and validate assessing tools that are specifically devoted to different groups of oncological patients. (www.actabiomedica.it)

References

1. Shaw J, Sethi S, Vaccaro L, et al. Is care really shared? A systematic review of collaborative care (shared care) interventions for adult cancer patients with depression. BMC health services research 2019, 19(1): 120.
2. Yao Z, Fang L, Yu Y, et al. Gender-disease interaction on brain cerebral metabolism in cancer patients with depressive symptoms. BMC psychiatry 2019, 19(1): 14
3. Olsen LR, Mortensen EL, & Bech P. Prevalence of major depression and stress indicators in the Danish general population. Acta Psychiatric Scand 2004, 109(2): 96-103.
4. Beck AT, Ward C, & Mendelson M. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4 (6): 561-571.
5. Zigmond AS, & Snaith RP. The hospital anxiety and depression scale. Acta Psychiatric Scand 1983, 67(6): 361-370.
6. Gómez‐Campelo P, Bragado‐Álvarez C, & Hernández‐Lloreda MJ. Psychological distress in women with breast and gynecological cancer treated with radical surgery. Psychooncology 2014, 23(4): 459-466.
7. Bergerot CD, Clark K, Nonino A, Waliany S, Buso MM, & Loscalzo M. Course of distress, anxiety, and depression in hematological cancer patients: Association between gender and grade of neoplasm. Palliative Support Care 2015, 13(2): 115-123.
8. Evers A, Muñiz J, Hagemeister C, et al. Assessing the quality of tests: Revision of the EFPA review model. Psicothema 2013, 25 (3): 283-291.
9. Costantini M, Musso M, Viterbori P, et al. Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Support Care Cancer 1999; 7: 121–7.
10. Miraglia Raineri A. Stressful life events and psychosocial factors in cancer: implications for assessment and treatment. PhD Dissertation. University of Florence 2014; BNI 2016-415T Unpublished doctoral dissertation.